Hemangiosarcoma
"Hemangiosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)
Descriptor ID |
D006394
|
MeSH Number(s) |
C04.557.450.795.390 C04.557.645.390
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemangiosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Hemangiosarcoma".
This graph shows the total number of publications written about "Hemangiosarcoma" by people in this website by year, and whether "Hemangiosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 | 2007 | 1 | 0 | 1 | 2009 | 1 | 0 | 1 | 2010 | 1 | 0 | 1 | 2012 | 1 | 0 | 1 | 2014 | 1 | 0 | 1 | 2017 | 1 | 0 | 1 | 2018 | 1 | 1 | 2 | 2021 | 2 | 0 | 2 | 2022 | 1 | 0 | 1 | 2023 | 1 | 0 | 1 | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hemangiosarcoma" by people in Profiles.
-
Schlein LJ, Brill SA, Brady RV, Farrell KB, Rose BJ, Meuten TK, Jordan CT, Thamm DH. Parthenolide As a Therapeutic for Disseminated Canine Neoplasms. J Pharmacol Exp Ther. 2024 02 15; 388(3):774-787.
-
M?ller JA, Delank KS, Laudner K, Wittenberg I, Zeh A, Vordermark D, Medenwald D. Clinical characteristics of sarcoma patients: a population-based data analysis from a German clinical cancer registry. J Cancer Res Clin Oncol. 2023 Dec; 149(19):17051-17069.
-
Leibowitz MS, Zelley K, Adams D, Brodeur GM, Fox E, Li MM, Mattei P, Pogoriler J, MacFarland SP. Neuroblastoma and cutaneous angiosarcoma in a child with PTEN hamartoma tumor syndrome. Pediatr Blood Cancer. 2022 10; 69(10):e29656.
-
Ushida Y, Sato T, Kato T, Shigematsu Y, Ito H, Suzuki T, Inoue Y, Ono Y, Oba A, Takahashi Y. Conversion surgery for recurrent hepatic angiosarcoma after systemic chemotherapy with paclitaxel. Clin J Gastroenterol. 2022 Apr; 15(2):427-432.
-
Florou V, Wilky BA. Current Management of Angiosarcoma: Recent Advances and Lessons From the Past. Curr Treat Options Oncol. 2021 06 07; 22(7):61.
-
Koo J, Knight-Perry J, Galambos C, Browne LP, Cost CR. Pediatric Metastatic Cardiac Angiosarcoma Successfully Treated With Multimodal Therapy: Case Report and Review of Literature. J Pediatr Hematol Oncol. 2021 03 01; 43(2):e203-e206.
-
Donisan T, Balanescu DV, Lopez-Mattei JC, Kim P, Leja MJ, Banchs J, Marmagkiolis K, Herrmann J, Gregoric I, Durand JB, Iliescu CA. In Search of a Less Invasive Approach to Cardiac Tumor Diagnosis: Multimodality Imaging Assessment and Biopsy. JACC Cardiovasc Imaging. 2018 08; 11(8):1191-1195.
-
Florou V, Wilky BA. Current and Future Directions for Angiosarcoma Therapy. Curr Treat Options Oncol. 2018 03 08; 19(3):14.
-
Winters AC, Black JO, Cost CR. Metastatic angiosarcoma arising in malignant peripheral nerve sheath tumor in a young patient with neurofibromatosis type 1. Pediatr Blood Cancer. 2017 Dec; 64(12).
-
Leech JD, Lammers SH, Goldman S, Auricchio N, Bronson RT, Kwiatkowski DJ, Sahin M. A vascular model of Tsc1 deficiency accelerates renal tumor formation with accompanying hemangiosarcomas. Mol Cancer Res. 2015 Mar; 13(3):548-55.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|